LONDON, Feb 29 (Reuters) – GlaxoSmithKline’s chairman is starting the process of seeking a new chief executive to succeed Andrew Witty, although a handover at the top of Britain’s biggest drugmaker…
The post GlaxoSmithKline starts hunt for successor to CEO Witty appeared first on NASDAQ.